Hematology and Transplant Center, Ospedale Oncologico di Riferimento Regionale "Armando Businco", Azienda Ospedaliera Brotzu, Cagliari, Italy..
Hematology and Transplant Center, Ospedale Policlinico San Martino, Genova, Italy.
Blood Rev. 2018 Jan;32(1):29-35. doi: 10.1016/j.blre.2017.08.005. Epub 2017 Aug 12.
Iron, although essential, is harmful in high amounts. Oxidative stress as a result of excess reactive oxygen species (ROS) and a prooxidative/antioxidative imbalance between ROS production and elimination, play a key role in cellular damage. There is evidence to support the role of ROS in the pathogenesis of a range of diseases including the myelodysplastic syndromes (MDS) and leukaemia. Oxidative stress seems to affect the self-renewal, proliferation and differentiation of haematopoietic stem cells and impair cell growth. Three aspects of these defective haemopoietic mechanisms may be associated with the activities of ROS: clonal evolution, haematological improvement and recovery of haemopoiesis after haematopoietic stem cell transplantation (HSCT). This review aims to provide haematologists with an overview of results from in vitro and murine models and preliminary clinical evidence on the diagnostic, prognostic and therapeutic implications of the complex interactions between the haemopoietic niche, iron, oxidative stress and inadequate haemopoiesis.
铁虽然是必需的,但含量过高也会有害。过多的活性氧(ROS)导致的氧化应激和 ROS 产生与消除之间的促氧化/抗氧化失衡,在细胞损伤中起着关键作用。有证据表明 ROS 在多种疾病的发病机制中起作用,包括骨髓增生异常综合征(MDS)和白血病。氧化应激似乎会影响造血干细胞的自我更新、增殖和分化,并损害细胞生长。这些造血机制缺陷的三个方面可能与 ROS 的活性有关:克隆进化、血液学改善和造血干细胞移植(HSCT)后造血恢复。本综述旨在为血液科医生提供有关体外和小鼠模型的结果概述,以及造血龛位、铁、氧化应激和造血功能不足之间复杂相互作用的诊断、预后和治疗意义的初步临床证据。